Topic Archives: Alzheimer’s Disease

Answered: “‘Perfect Storm’ Stock Is Set to Deliver Big Pharma a Swift and Devastating DEATHBLOW”

Here’s the lead-in to the ad that caught our readers’ attention this week: “This ‘Perfect Storm’ Stock Is Set to Deliver Big Pharma a Swift and Devastating DEATHBLOW It Won’t Come Back From… “And Launch This Little Company on A 72-Hour, $8.98 Billion All-Out SPRINT” And there’s a deadline… today, in fact, when there will […]

Friday File: Blanco’s “Alzheimer’s Disease is Completely Treatable” pitch for the “Revolutionary ‘TREM-2 Repair’ Protocol”

Ray Blanco makes (part of) his living looking for biotech moonshots, like most biotech-focused newsletter writers — and like his predecessor at Agora’s biotech and emerging tech-focused newsletter Breakthrough Technology Alert, he has often touted companies that are trying to end the scourge of Alzheimer’s Disease. Why? Well, two main reasons: First, and by far […]

“Sig-1” and the Reversal of “79-Year-Old Grandma’s Alzheimer’s” pitched by Casey

We are always, always tempted by anything that promises hope to sufferers of Alzheimer’s Disease and their families… not just because we’re humanitarians and love people, and have seen the pain of this disease, but because Alzheimer’s treatment is by far the largest (mostly) unmet medical need in the US, both because the population of […]

What’s Dave Lashmet’s “Biggest Ever Breakthrough for treating Alzheimer’s Disease?”

Alzheimer’s Disease always gets a lot of attention from newsletter publishers, readers and investors — not only because we all know someone who suffers from this terrible malady, but because we know that the current treatments are ineffective and the market is huge… which means that any real solutions or more effective treatments could create […]

“How a Company You’ve Never Heard of Could End Alzheimer’s Disease and Save America’s Financial Future”

That’s a subtle headline, right? I already issued a bit of a “brain dump” for the Irregulars this week, on Wednesday instead of Friday, but I couldn’t resist taking a little look at this latest teaser pitch from Patrick Cox for his Transformational Technology Alert. Quite a few readers have been asking about it, and […]

Comments

  • Gr8Full!

    Virtual reality can spot navigation problems in early Alzheimer's disease by University of Cambridge https://medicalxpr...

  • Avatar

    Fred, sorry I missed your comment on L-serine. Have you found another source that taste's ok/better? I have not found...

  • Travis Johnson, Stock Gumshoe

    Another failure in Alzheimer's Disease trials... BIIB and Eisai discontinued their late Phase 3 trials because they were...

  • Avatar

    This is a business there will he sales nonsense and I looked before I bought in bought in about their opt out policy. Th...

  • Avatar

    What is Ray Blonco's "Alzheimer’s Disease cure" 4olbear....

  • Avatar

    Anybody with experience using L-serine for preventative for ALS Alzheimers?; I can not find on retail market. I read an...

  • Avatar

    There may be something behind this. A 2017 book "The End of Alzheimer's..." published by Penguin/Random House, written b...

  • Gr8Full!

    #86AD > Mandelblatt cautioned that her study was still too small to reach any conclusion, but if future studies could re...

  • Travis Johnson, Stock Gumshoe

    I hope it works well for you, and that their drug is both effective and profitable. I've gotten very skeptical about Al...

  • Avatar

    Hello Doc, All, I have hesitated to mention this company involved in this field, but since we are on a common thread, na...

  • Michael Jorrin,

    Many interesting comments in response to that Alzheimer’s piece. I’ll try to respond to as many as I can. And ma...

  • Avatar

    Hi Doc. What do you think about ANAVEX ? They are starting a phase 3 and here are the recent bullets. One huge positive ...

  • Gr8Full!

    What does running do to your #brain? https://pbs.twimg.com/media/DhHfG2ZWAAYz_xC.jpg ty https://twitter.com/LEAD_C...

  • Gr8Full!

    New development in 3-D super-resolution imaging gives insight on Alzheimer's disease https://phys.org/news/2018-07-d-su...

  • Gr8Full!

    $AXSM > Bid 204K at $3.05 Axsome Therapeutics Announces AXS-05 Presentation at the 2018 Alzheimer's Association Interna...

  • Gr8Full!

    Yet More Evidence that Viruses May Cause Alzheimer's Disease https://gizmodo.com/yet-more-evidence-that-viruses-may-cau...

  • Travis Johnson, Stock Gumshoe

    Excitement about Alzheimer's drugs sometimes spurs big movements in Phase 1 and 2, though so far almost all of them have...

  • Avatar

    I'm trying to assess the opportunity for an investment in Promis Neurosciences. They are a pre-clinical stage biotech co...

  • Gr8Full!

    $VTVT np - vTv Therapeutics Inc. has added a news release to its Investor Relations website. Title: vTv Therapeutics ...

  • Gr8Full!

    $VTVT np - vTv Therapeutics Announces Topline Results from the First STEADFAST Phase 3 Study Evaluating Azeliragon in Pe...

  • Avatar

    See research at Paul H. Duray Pathology Research Fellowship that show borrelia burgdorferi aka Lyme disease spirochetes ...

  • Gr8Full!

    Dysregulation of the epigenetic landscape of normal aging in Alzheimer’s disease https://www.nature.com/articles/s415...

  • Gr8Full!

    $ORY.BME - Oryzon to present at upcoming international conferences Madrid, Spain and Cambridge, MA - February 21st 20...

  • Gr8Full!

    #AD - Arthritis drugs could halve the risk of Alzheimer's disease, study suggests http://www.telegraph.co.uk/news/2018/...

  • Gr8Full!

    #AD - PMN.to NP - As someone who lost their father to alzheimer's disease, I did a fair bit of research into this compan...

  • Avatar

    $CWBR #MDPs New research article published in the journal of Alzheimer’s and Dementia supports a mitochondria(MDP)-b...

  • SoGiAm

    #AD #Tunes Another joy to parents/patients with Alzheimer's Disease is playing/listening to their favorite #music. Some...

  • Avatar

    Yep, there is a very wide gulf separating "Alzheimer’s Disease is Now Completely Treatable”" and "could give hope to...

  • Avatar

    #Alzheimer's Disease $CWBR Article: Dementia Shown Associated with Synaptic Dysfunction Rather Than Synaptic Loss GEN N...

  • Avatar

    Question of the week Maybe a bit of a trick question? My quick research says that the answer is HDV. It also says t...

  • Avatar

    NTRP-NP. Looking for $6.55 ( untested low) for SP. I am surprised that there hasn't been more interest in this outfit. R...

  • Avatar

    $AXSM UW Axsome announces recommendations to continue COAST-1, discontinue CREATE-1 trial Axsome Therapeutics an...

  • Avatar

    #Alzheimers Disease $Biogen$Merck$J&J$Denali Nice summary article in WSJ "Drug Industry Isn't Giving Up On Alzheimer's" ...

  • SoGiAm

    TRAVIS, LYNN, #ZKSS one in Moderation replaced by this one... #Alzheimer's #Disease #AD… The Neuroscience Inno...

  • SoGiAm

    $NTRP np - https://www.morningstar.com/news/pr-news-wire/PRNews_20171219NY73157/neurotrope-to-present-additional-findin...

  • Avatar

    $NTRP (long) [Post-hoc subgroup analysis of Phase 2 patients, completed May 2016, shows that Bryostatin had an appare...

  • Avatar

    $PFE Pfizer Ends Hunt for Drugs to Treat Alzheimer’s and Parkinson’s - About 300 layoffs to take place after once...

  • Avatar

    $Alzheimer Hi John, scary indeed. Last I heard the role of tau-phosphorylation in the pathogenesis of Alzheimers Dis...

  • Avatar

    $Alzheimers $AD (A great read of new research findings) Alzheimer’s protein may spread like an infection, human...

  • SoGiAm

    #Alzheimer'sDisease - Healthy mitochondria could stop Alzheimer's Date: December 6, 2017 Source: Ecole Polytechnique F...

  • SoGiAm

    #Alzheimer's Disease related - How Loneliness Affects Our Health https://www.nytimes.com/2017/12/11/well/mind/how-lonel...

  • SoGiAm

    Grief is convoluted but does have two "messy" phases: LOSS -as you plunge into a pit of pain and confusion, and then, ...

  • SoGiAm

    #Alzheimer's Disease related - http://fortune.com/2017/12/01/human-longevity-dna-ceo-out/...

  • SoGiAm

    #Alzheimer’s Disease Protective Alzheimer’s Gene Variant Uncovered ---> Linkage, whole genome sequence, and biologi...

  • Avatar

    #Alzheimer's Disease Protective Alzheimer's Gene Variant Uncovered https://genomemedicine.biomedcentral.com/articles/10....

  • Avatar

    Michael Jorrin - This was posted on the ihub message board this morning. This is too lengthy for your comment section bu...

  • Avatar

    My research into Alzheimer’s potential “cures” or drugs that do not attack the disease from the amyloid plaque ang...

  • Avatar

    What do you think about "Anavex Life Sciences Says Study of ANAVEX2-73 Shows Improvement in Alzheimer's Disease Patients...

  • Avatar

    Are you aware of the work by Dr Dale Bredesen? Here is a summary of that work as reported by Dr Mercola on his website:...

  • Avatar

    $ AXSM NP : (AXSM) More News 08-Nov-2017:07:00:00, Axsome Therapeutics Reports Third Quarter 2017 Financial R...

  • Avatar

    $Anti-aging $Mitochondria (?) An exciting new research report from NATURE (11/1) “Infusions of young blood tes...

  • Avatar

    $AXON np #FAIL Announces Negative Topline Results of Intepirdine Phase 3 MINDSET Trial in Alzheimer's Disease http:/...

  • Avatar

    $AXON -- I wish I had the guts to short this. Interesting piece on Alzheimers but doc is embargoed 'til December. Long-...

  • SoGiAm

    #Alzheimer's_Disease - $BIIB - Biogen Reports New Data from Phase 1b Study of Investigational Alzheimer’s Disease Trea...

  • SoGiAm

    #Alzheimers _Hypothesis “Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer’s Disease.” St...

  • SoGiAm

    #Alzheimers _Hypothesis “Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer’s Disease.” St...

  • Avatar

    $Alzheimers $Hypothesis "Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer's Disease." Sternb...

  • Avatar

    I wrote today about a different Alzheimer's Disease drug being tested in mice, not the one Doc Gumshoe mentioned. It als...

  • SoGiAm

    $AXSM long - Prognosticating report and update tomorrow, Aug 9th, as that was the date last year. http://finviz.com/qu...

  • SoGiAm

    Molecular link between post-traumatic stress disorder and Alzheimer's disease https://medicalxpress.com/news/2017-08-m...

  • Avatar

    Interesting article. This seems to support the positive affect of Doxycycline for AD as it passes the BBB easily. A tria...

  • Avatar

    $NTRP Neurotrope Presents Phase 2 Data Assessing Bryostatin-1 in Moderate-to-Severe Alzheimer's Patients at AAIC 201...

  • SoGiAm

    $AXSM long - Title: Axsome Therapeutics Initiates Phase 2/3 Trial of AXS-05 for Alzheimer's Disease Agitation http://...

  • Avatar

    $Diabetes $Obesity $Alzheimers Disease "Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disea...

  • SoGiAm

    Scientists uncover the structure of tau filaments from Alzheimer’s disease https://medicalxpress.com/news/2017-07-atom...

  • SoGiAm

    Scientists uncover the structure of tau filaments from Alzheimer's disease https://medicalxpress.com/news/2017-07-atomic...

  • SoGiAm

    $CUR np - Neurotrope to Present Bryostatin Phase 2 Data in an Oral Presentation at AAIC 2017 Meeting NEW YORK - June 29...

  • SoGiAm

    #Alzheimer's Prevention - interesting new findings published in Medscape "Olive Oil Key Ingredient in Alzheimer's Pre...

  • SoGiAm

    #Alzheimer's Prevention - interesting new findings published in Medscape "Olive Oil Key Ingredient in Alzheimer's Pre...

  • Avatar

    #Alzheimer's Prevention - interesting new findings published in Medscape "Olive Oil Key Ingredient in Alzheimer's Pre...

  • Travis Johnson, Stock Gumshoe

    I think folks have tired of the constant promise -- AVXL has been pitched as an "Alzheimer's Cure" company for almost a ...

  • Avatar

    $EBIX long and OW (but not like $AUPH!) This is the stock that got away from the Fool. I can't believe they never res...

  • Travis Johnson, Stock Gumshoe

    They'd certainly like to believe they are. Anavex's drugs have been overpromised so many times over the years that I gr...

  • Avatar

    No $ticker. For those who have loved ones suffering from Alzheimer’s Disease, as I do, perhaps this is an alternative ...

  • Avatar

    Where to I go for Number 3. 3.A weird-looking mushroom from Europe that can REVERSE the effects of Alzheimer’s Disease...

  • SoGiAm

    $AXSM - Axsome Therapeutics Receives FDA Fast Track Designation for AXS-05 for Alzheimer's Disease Agitation Globe News...

  • Avatar

    $NTRP: Neurotrope Alzheimer's Trial Shows Top Line Efficacy in Hardest to Treat Patients Accesswire May 2, 201 Re...

  • Avatar

    $NTRP phew! glad you posted that Dr KSS. It's down pre-mkt but coming nicely off the bottom since you posted. Neurotr...

  • Avatar

    $NTRP Long Neurotrope Bioscience to Release Results From Phase 2 Clinical Trial in Moderate to Severe Alzheimer's Disea...

  • Avatar

    $AXSM: Initial AXS-02 Phase 3 trial data readout expected in 4Q17. AXS-02 is in Phase 3 development with Fast Track stat...

  • SoGiAm

    $TDSGF - 3D Signatures’ TeloView™ Software Identifies and Stages Patients With Alzheimer’s Disease From a Cheek Sw...

  • Avatar

    Interesting and well written article. Thank you. It's particularly disturbing how little progress modern medicine has ...

  • Avatar

    I heard back from the Alzheimer’s foundation I donate to about the bexarotene study: "To summarize the results from wh...

  • Anamorph

    Sometime back I was reading an article which mentioned an executive (can't remember the name) who had previously been at...

  • Avatar

    $NTRP The market does not seem too excited by the news out today, no change in stock price. I recall there are at least ...

  • Avatar

    Myron are you seriously calling Alzheimer's Disease a "lifestyle disease" caused by a lousy diet?? You claim that folk ...

  • Avatar

    Layman's article: THE NEW OFFENSIVE ON ALZHEIMER’S DISEASE: STOP IT BEFORE IT STARTS http://www.newsweek.com/2017/...

  • Avatar

    $NTRP (long) I just wanted to point out that there was a corporate presentation today, which included a discussion (by ...

  • Avatar

    $ESPR long Arthur Toga, PhD, head of the brain imaging and mapping center at USC, Professor of Neurology, Ophthalmolo...

  • SoGiAm

    Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer's disease https://academic.oup.c...

  • SoGiAm

    May you re-post the contents please, bigger? There are many equities chasing Alzheimer's Disease. You may be interes...

  • SoGiAm

    Chris27, notice that you have very few HN score A & B equities. You maybe able to trade pre-and post-market hours us...

  • Avatar

    JPM 17 $ACAD webcast: expects to start Phase3 Pimavanserin Alzheimers Disease Psyhosis (ADP) late 2017. http://jpmorg...

  • Avatar

    JPM17 $ACAD webcast: http://jpmorgan.metameetings.com/confbook/healthcare17/directlink.php?p=22606 Initiating Phase 3...

  • Dr. KSS MD PhD

    I think we really do not know that. If Alzheimer's disease were a pathology affecting any other organ, how would we mana...

  • Avatar

    $AXSM: Axsome Therapeutics Receives FDA Clearance of IND for Phase 2/3 Trial of AXS-05 in Alzheimer’s Disease Agita...

  • Avatar

    Hi everyone, I ask for your patience as I am just learning the ropes. I have much to learn but am excited about the op...

  • Avatar

    For your viewing pleasure: an excellent animation of Alzheimer's Disease http://www.nature.com/neuro/multimedia/alzhe...

  • Avatar

    Re: Alzheimer’s disease: “The memory deficits we observed in mouse prion disease were completely restored by treatme...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch